Uptick Seen in Mpox Cases in Chicago
TUESDAY, May 9, 2023 (HealthDay News) — While the mpox outbreak has been waning since last summer, it has not disappeared yet. Howard Brown Health, an LGBTQ-focused health clinic in Chicago, recently reported seeing an increase in mpox cases, with ei…
Learn MoreUptick Seen in Mpox Cases in Chicago
TUESDAY, May 9, 2023 (HealthDay News) — While the mpox outbreak has been waning since last summer, it hasn’t disappeared yet. Howard Brown Health, a LGBTQ-focused health clinic in Chicago, recently reported seeing an increase in mpox (formerly known …
Learn MoreLa mente podría contener pistas sobre el riesgo de COVID prolongada
VIERNES, 5 de mayo de 2023 (HealthDay News) — Mientras intentaban desentrañar los misterios de la COVID prolongada, unos investigadores encontraron que la ansiedad y la depresión podrían tener un rol en algunas personas con la afección persistente.En…
Learn MoreLa OMS declara el fin de la emergencia mundial por la COVID
VIERNES, 5 de mayo de 2023 (HealthDay News) — Más de tres años después de que el coronavirus comenzara a asolar el planeta, la Organización Mundial de la Salud (OMS) anunció el viernes que la pandemia ya no es una emergencia de salud pública.”Declaro…
Learn MoreWHO Declares COVID Global Emergency Over
FRIDAY, May 5, 2023 (HealthDay News) — More than three years after the coronavirus began ravaging the planet, the World Health Organization (WHO) announced Friday that the pandemic is no longer a public emergency.“It’s with great hope that I declare …
Learn MoreMind May Hold Clues to Your Risk of Long COVID
FRIDAY, May 5, 2023 (HealthDay News) — In trying to untangle the mysteries of long COVID, researchers have found anxiety and depression may play a role for some of those with the lingering condition. In the study from researchers at University of Cal…
Learn MoreFDA Approves First RSV Vaccine
WEDNESDAY, May 3, 2023 (HealthDay News) — The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 years and older. Arexvy is expected to help prevent lower respirat…
Learn MoreFDA Approves First RSV Vaccine
WEDNESDAY, May 3, 2023 (HealthDay News) — The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.Arexvy, manufactured by GlaxoSmithKline (GSK), is expect…
Learn MoreHIV Status Does Not Affect Outcomes of Tecovirimat Treatment for Mpox
MONDAY, May 1, 2023 (HealthDay News) — HIV status seems not to affect treatment outcomes among patients receiving tecovirimat for mpox, according to a study published online May 2 in the Annals of Internal Medicine.Jacob McLean, D.O., from the Columb…
Learn MoreNo hay ningún caso de viruela símica en más de una semana por primera vez desde el inicio del brote: CDC
VIERNES, 28 de abril de 2023 (HealthDay News) — Por primera vez desde el principio del brote de viruela símica (mpox) la primavera pasada, no se ha reportado ningún caso nuevo en más de una semana, muestran unos nuevos datos del gobierno.Durante el p…
Learn More